Disease | glomerulosclerosis |
Phenotype | C0022658|kidney disease |
Sentences | 11 |
PubMedID- 22541678 | Chronic kidney disease, probably due to progressive glomerulosclerosis, and high-tone sensorineural deafness were evident. |
PubMedID- 25648269 | He had undergone a kidney transplant ten years earlier for end-stage kidney disease with focal segmental glomerulosclerosis at that time, he received a living kidney allograft from his 51-year-old father. |
PubMedID- 23915644 | Urinary protein/creatinine ratio >1g/g, egfr <45 ml/min/1.73m2 or biopsy-proven glomerulosclerosis are associated with progressive kidney disease or a sub-optimal response to ert[6,70,71], suggesting that these non-invasive biochemical assessments provide insights into both the underlying tissue pathology and response to ert. |
PubMedID- 24599252 | An additional difficulty comes from the observation that any form of familial (or non-familial) kidney disease that leads to secondary glomerulosclerosis can be mislabeled as idiopathic fsgs. |
PubMedID- 23966810 | Obesity is involved in the onset and progression of diabetic nephropathy, hypertensive nephropathy, and chronic kidney disease (ckd) due to glomerulosclerosis,13,14 and is closely associated with hyperuricemia.15–17 since hyperuricemia, like obesity, is a factor exacerbating renal impairment,9–11 it is necessary to prevent the progression of renal impairment by treating hyperuricemia co-existing with obesity. |
PubMedID- 25129203 | Background: a high prevalence of chronic kidney disease among children with focal segmental glomerulosclerosis (fsgs) leads to a permanent quest for good predictors of kidney dysfunction. |
PubMedID- 25016146 | Obesity has been reported as an independent risk factor for chronic kidney disease, leading to glomerulosclerosis and renal insufficiency. |
PubMedID- 22443450 | Further studies are needed to elucidate whether and how a low catalase activity in humans influences either albuminuria or glomerulosclerosis associated with kidney diseases. |
PubMedID- 23399084 | Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (fsgs ct). |
PubMedID- 20124285 | H-eskd is also likely a primary kidney disease in spectrum of fsgs (focal global glomerulosclerosis), without extrarenal manifestations except for secondarily elevated blood pressures. |
PubMedID- 21635713 | An admixture signal on chromosome 22q13 was found for focal segmental glomerulosclerosis, a cause of end-stage kidney disease, in african americans [53,54]. |
Page: 1